Australia markets open in 4 hours 42 minutes

NovaBay Pharmaceuticals Inc (B9P.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
4.3400+4.2160 (+103.03%)
As of 08:08AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
12,151
14,726
14,404
10,204
9,934
-
Cost of revenue
5,317
6,831
6,623
3,689
3,970
-
Gross profit
6,834
7,895
7,781
6,515
5,964
-
Operating expenses
Research development
116
68
174
44
285
-
Selling general and administrative
14,903
12,830
15,287
15,333
12,105
-
Total operating expenses
15,019
12,898
15,461
15,377
12,390
-
Operating income or loss
-8,185
-5,003
-7,680
-8,862
-6,426
-
Total other income/expenses net
5,625
-4,637
-2,928
3,038
-4,608
-
Income before tax
-2,560
-9,640
-10,608
-5,824
-11,034
-
Income tax expense
0
-
-
0
5
6
Income from continuing operations
-2,560
-9,640
-10,608
-5,824
-11,039
-
Net income
-2,560
-9,640
-10,608
-5,824
-11,039
-
Net income available to common shareholders
-8,952
-16,697
-16,265
-6,559
-11,039
-
Basic EPS
-7.05
-3.96
-10.10
-5.26
-10.85
-
Diluted EPS
-7.05
-3.96
-10.10
-5.26
-10.85
-
Basic average shares
2,958
4,215
1,610
1,247
1,002
-
Diluted average shares
2,958
4,215
1,610
1,247
1,002
-